FDA approves Mounjaro diabetes drug to be prescribed for weight loss How Zepbound Works for Obstructive Sleep Apnea Mtg Alter Custom Altered Magic the Gathering Cards Art Huge news: FDA has approved Zepbound (tirzepatide GLP 1 GIP receptor agonist) for the treatment of moderate to severe obstructive sleep apnea in adults with obesity. As a cardiologist, this is a huge deal FDA approves Wegovy for lowering heart attack and stroke risk in overweight patients Cheryl Burke Explains New Look After Shutting Down Ozempic & Face Lift Rumors